Stathmin 1 expression in neuroendocrine and proliferating prostate cancer
Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality among men in the United States. While PCa initially responds to androgen deprivation therapy, a significant portion progresses to castration-resistant PCa. Approximately 20–25% of these cases acquire aggressive ne...
Saved in:
| Main Authors: | Yingli Shi, Yunshin A. Yeh, Siyuan Cheng, Xin Gu, Shu Yang, Lin Li, Nazih P. Khater, Susan Kasper, Xiuping Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-01-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-01754-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
by: Henrica M J Werner, et al.
Published: (2014-01-01) -
Rac1 and Stathmin but Not EB1 Are Required for Invasion of Breast Cancer Cells in Response to IGF-I
by: Shigeru Morimura, et al.
Published: (2011-01-01) -
Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01) -
Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells
by: Abrar Samiea, et al.
Published: (2020-01-01) -
Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)